Breakthrough HBV infection in vaccinated children in Taiwan: Surveillance for HBV mutants

Antiviral Therapy

Volumn 15, Issue 3 PART B, 2010, Pages 463-469

  Chang, Mei Hwei ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

CHILD; DRUG COST; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; INTRAUTERINE INFECTION; LIVER CELL CARCINOMA; MASS IMMUNIZATION; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TAIWAN; VIRUS GENE; VIRUS LOAD; VIRUS MUTANT; WILD TYPE; ADOLESCENT; BLOOD; GENETICS; HEALTH SURVEY; HETEROZYGOTE; IMMUNOLOGY; MUTATION; PREVALENCE; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VACCINATION; VIROLOGY;

ADOLESCENT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MUTATION; POPULATION SURVEILLANCE; PREVALENCE; TAIWAN; VACCINATION;

EID: 77953423810     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1555     Document Type: Review

References (40)

1. Ganem D, Prince AM. Hepatitis B virus infection natural history and clinical consequences. N Engl J Med 2004; 350:1118-1129.
2. Feret E, Larouze B, Dip B, Sow M, London WT, Blumberg BS. Epidemiology of hepatitis B virus infection in the rural community of Tip, Senegal. Am J Epidemiol 1987; 125:140-149.
3. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J Med Virol 1986; 18:301-307.
4. Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 1975; 292:771-774.
5. Chen HL, Chang MH, Ni YH, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996; 276:906-908.
6. Ni YH, Chang MH, Huang LM, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796-800.
7. Ni YH, Huang LM, Chang MH, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007; 132:1287-1293.
8. Chang MH, Chen CJ, Lai MS, et al. Unviersal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336:1855-1859
9. Chang MH, Chen J, Hsu HM, et al. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B Virus: the effect and problems. Clin Cancer Res 2005; 11:7953-7957
10. Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Unviersal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001; 139:349-352
11. Shepard CW, Simard EP, Finelli L, Fiore AF, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28:112-125.
12. Hsu HM, Chen DS, Chuang CH, et al. Efficacy of a mass hepatitis B vaccination program in Taiwan: studies on 3464 infants of hepatitis B surface antigen-carrier mothers. JAMA 1988; 260:2231-2235.
13. Beasley RP, Hwang LYG, Lee GCY, et al. Prevention of Perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983; 322:1099-1102.
14. Fortuin M, Karthigesu V, Allison L, et al. Breakthrough infections and identification of a novel variant in Gambian children immunized with hepatitis B vaccine. J Infect Dis 1994; 169:1374-1376.
15. Whittle HC, Inskip H, Hall AJ, et al. Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia. Lancet 1991; 337:747-750.
16. Most J, Larcher C, Vogetseder W, et al. Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students. Vaccine 1992; 10:740-741.
17. WHO position paper. Hepatitis B vaccines. Wkly Epidemiol Rec 2004; 79:255-263.
18. Chen DS, Hsu NH, Sung JL, et al. A mass vaccination program in Taiwan against hepatitis B surface antigen carrier mothers. JAMA 1987; 257:2597-2603.
19. Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR Recomm Rep 2005; 54:1-31.
20. Poovorawan Y, Theamboonlers A, Vimolket T, et al. Impact of hepatitis B immunization as part of the EPI. Vaccine 2000; 19:943-949.
21. Tsen YJ, Chang MH, Hsu HY, et al. Seroprevalence of hepatitis B infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program. J Med Virol 1991; 34:96-99.
22. Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis 2003; 187:134-138.
23. del Canho R, Grosheide PM, Schalm SW, de Vries RR, Heijtink RA. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994; 20:483-486.
24. Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr 1998; 133:374-377.
25. van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 2003; 10:294-297.
26. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009; 16:94-103.
27. Lin HH, Lee TY, Chen DS, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111:877-881.
28. Carman WF, Zanetti AR, Karayianis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336:325-329.
29. Hsu HY, Chang MH, Ni YH, et al. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology 1997; 26:786-791.
30. Ngui SL. O'connell S, Eglin RP, Hepatonstall J, Teo CG. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J Infect Dis 1997; 176:1360-1365.
31. Howard CR, Allison LMC. Hepatitis B surface antigen variation and protective immunity. Intervirology 1995; 38:35-40.
32. Carman WF, van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology 1997; 26:1658-1666.
33. Gerin JL, Alexander H, Shih JWK, et al. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc Natl Acad Sci U S A 1983; 80:2365-2369.
34. Chiou HL, Lee TS, Kuo J, Mau YC, Ho MS. Altered antigenicity of a determinant variants of hepatitis B virus. J Gen Virol 1997; 78:2639-2645.
35. Coleman PF. Detecting hepatitis B surface antigen mutants. Emerg Infect Dis 2006; 12:198-203.
36. Ogata N, Cote PJ, Zanetti AR, et al. Licensed recombinant hepatitis B vaccines protect against infection with the prototype surface gene mutant of hepatitis B virus. Hepatology 1999; 30:779-786.
37. Hsu HY, Chang MH, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30:1312-1317.
38. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after nationwide vaccination program in Taiwan. Gut 2004; 53:1499-1503.
39. Mendy M, D'Mello F, Kanellos T, Oliver S, Whittle H, Howard CR. Envelope protein variability among HBV-Infected asymptomatic carriers and immunized children with breakthrough infections. J Med Virol 2008; 80:1537-1546.
40. Surya IGP, Kishimato S, Sudaryat S, et al. Prevention of mother-to-infant transmission of hepatitis B virus with use of a pre-S2-containing vaccine in Bali, Indonesia. Vaccine Res 1996; 5:203-213.